Kyoto Women's University, Japan.
Am J Chin Med. 2010;38(3):561-8. doi: 10.1142/S0192415X10008056.
Lindera strychnifolia (Tendai-Uyaku), a medicinal plant, has long been used for the treatment of cardiac, renal and rheumatic diseases in Japan. We investigated the effect of Lindera strychnifolia on systolic blood pressure, cardiac function, and plasma noradrenaline levels in rats. Spontaneously hypertensive rats (SHR) were given free access to water or extract solution of Lindera strychnifolia, which was extracted with a ratio of 10 g Lindera strychnifolia roots/20 ml water. Systolic blood pressure was measured by using a tail-cuf sphygmomanometer twice a week from 10 to 30 weeks of age, and compared to the age-matched Wistar Kyoto rats (WKY) as a control group. At 30 weeks of age, heart function was measured by echocardiography and blood samples were taken for detection of plasma noradrenaline levels, and rats were then sacrificed. Systolic blood pressure gradually increased from 10 to 30 weeks of age in the SHR group, while it did not change in the WKY group. In the Lindera-treated SHR group, the increase in systolic blood pressure was significantly attenuated from 21 to 30 weeks of age. Echocardiography showed a significant increase in ejection fraction in the Lindera-treated SHR group (60.4 +/- 7.8%) as compared to the SHR group (39.7 +/- 23.4%). Plasma noradrenaline levels were significantly decreased in Lindera-treated SHR group compared to the SHR group. These results suggest that Lindera strychnifolia has an anti-hypertensive effect and improves cardiac function in spontaneous hypertensive rats. These effects may be related to the decrease in plasma noradrenaline levels by Lindera strychnifolia.
乌药(Lindera strychnifolia(Tendai-Uyaku)),一种药用植物,长期以来一直被用于治疗日本的心脏、肾脏和风湿疾病。我们研究了乌药对收缩压、心功能和血浆去甲肾上腺素水平的影响。自发性高血压大鼠(SHR)自由饮用水或乌药提取物溶液,乌药提取物的提取比例为 10 克乌药根/20 毫升水。从 10 至 30 周龄,每周两次使用尾套式血压计测量收缩压,并与年龄匹配的 Wistar Kyoto 大鼠(WKY)作为对照组进行比较。在 30 周龄时,通过超声心动图测量心功能,并采集血样检测血浆去甲肾上腺素水平,然后处死大鼠。在 SHR 组中,收缩压从 10 至 30 周龄逐渐升高,而在 WKY 组中则没有变化。在乌药治疗的 SHR 组中,从 21 至 30 周龄,收缩压的升高明显减弱。超声心动图显示,乌药治疗的 SHR 组(60.4±7.8%)射血分数明显增加,而 SHR 组(39.7±23.4%)则没有。与 SHR 组相比,乌药治疗的 SHR 组血浆去甲肾上腺素水平明显降低。这些结果表明,乌药具有抗高血压作用,并改善自发性高血压大鼠的心功能。这些作用可能与乌药降低血浆去甲肾上腺素水平有关。